0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

PULMONARY CAVITATION DUE TO POLYARTERITIS

BENJAMIN P. SANDLER, M.D.; JAMES H. MATTHEWS, M.D.; SIEGBERT BORNSTEIN, M.D.
JAMA. 1950;144(9):754-757. doi:10.1001/jama.1950.62920090001008.
Text Size: A A A
Published online

Polyarteritis as a disease entity was first described by Kussmaul and Maier in 1866 under the name of periarteritis nodosa.1 Until 1937 about 20 cases had been diagnosed clinically.2 Since 1937 the number of cases recognized during life has increased greatly due to increased awareness of and interest in the disease. It is difficult to state whether or not there has been an actual increase in the incidence of the disease. Since cases are being attributed to sensitization to a variety of therapeutic agents, such as sulfonamide drugs, heavy metals, iodides and phenylhydantoin sodium, the growing number and increased use of these agents may be responsible in part for any greater incidence. Periarteritis nodosa has also been attributed to sensitization by plant poisons.3 Conceivably, any substance known to produce allergic manifestations is a potential etiologic factor. When one takes into consideration the millions of persons who have

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();